CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...